XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.0.1
Financial Instruments - Cash, Cash Equivalents and Marketable Securities by Investment Category (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Dec. 30, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Cash $ 234,980   $ 144,184
Unrealized Gain 50   122
Unrealized Loss (13)   0
Total 327,820   221,036
Total 327,857   221,158
Cash and cash equivalents 279,955 $ 169,732 169,732
Marketable Securities 47,902 $ 51,426 51,426
Level 1:      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Cash equivalents 40,881   25,548
Amortized Cost 40,881   25,548
Estimated Fair Value 40,881   25,548
Level 1: | Money market funds      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Amortized Cost 40,881   25,548
Cash equivalents 40,881   25,548
Estimated Fair Value 40,881   25,548
Level 2:      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Amortized Cost 51,959   51,304
Cash equivalents 4,094   0
Unrealized Gain 50   122
Unrealized Loss (13)   0
Estimated Fair Value 51,996   51,426
Marketable Securities 47,902   51,426
Level 2: | U.S. Treasury securities      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Amortized Cost 51,959   51,304
Cash equivalents 4,094   0
Unrealized Gain 50   122
Unrealized Loss (13)   0
Estimated Fair Value 51,996   51,426
Marketable Securities $ 47,902   $ 51,426